Speedy delivery: Biodegradable and biocompatible polymers and lipids form hybrid core/shell nanoparticles (see picture, left) that show promising in vitro and in vivo results for delivering siRNA. The unique lipid–polymer–lipid nanostructure is elucidated by electron and fluorescence microscopy (right) and provides the delivery system with distinct functional features
International audienceRNA interference discovery has opened up new fields of study, including the un...
Therapeutics based on small interfering RNA (siRNA) have promising potential as antiviral and anti-i...
The development of controlled-release nanoparticle (NP) technologies has great potential to further ...
The clinical success of therapeutics of small interfering RNA (siRNA) is still hindered by its deliv...
Over the last decade, impressive progress in the field of nanomedicine has led to the development of...
Lipid-polymer hybrid nanoparticles (LPHNPs) are next-generation core-shell nanostructures, conceptua...
The present work proposes a unique de-PEGylation strategy for controllable delivery of small interfe...
Understanding the delivery dynamics of nucleic acid nanocarriers is fundamental to improve their des...
Anubhab Mukherjee,1,2 Ariana K Waters,1,2 Pranav Kalyan,3 Achal Singh Achrol,2 Santosh Kesari,2 Venk...
International audienceVectorized small interfering RNAs (siRNAs) are widely used to induce gene sile...
Polymeric nanoparticles and liposomes have been the platform of choice for nanoparticle-based cancer...
Nanoparticles represent particularly attractive delivery systems for small interfering RNA (siRNA) a...
Therapeutics based on small interfering RNA (siRNA) have promising potential as antiviral and anti-i...
International audienceRNA interference discovery has opened up new fields of study, including the un...
Therapeutics based on small interfering RNA (siRNA) have promising potential as antiviral and anti-i...
The development of controlled-release nanoparticle (NP) technologies has great potential to further ...
The clinical success of therapeutics of small interfering RNA (siRNA) is still hindered by its deliv...
Over the last decade, impressive progress in the field of nanomedicine has led to the development of...
Lipid-polymer hybrid nanoparticles (LPHNPs) are next-generation core-shell nanostructures, conceptua...
The present work proposes a unique de-PEGylation strategy for controllable delivery of small interfe...
Understanding the delivery dynamics of nucleic acid nanocarriers is fundamental to improve their des...
Anubhab Mukherjee,1,2 Ariana K Waters,1,2 Pranav Kalyan,3 Achal Singh Achrol,2 Santosh Kesari,2 Venk...
International audienceVectorized small interfering RNAs (siRNAs) are widely used to induce gene sile...
Polymeric nanoparticles and liposomes have been the platform of choice for nanoparticle-based cancer...
Nanoparticles represent particularly attractive delivery systems for small interfering RNA (siRNA) a...
Therapeutics based on small interfering RNA (siRNA) have promising potential as antiviral and anti-i...
International audienceRNA interference discovery has opened up new fields of study, including the un...
Therapeutics based on small interfering RNA (siRNA) have promising potential as antiviral and anti-i...
The development of controlled-release nanoparticle (NP) technologies has great potential to further ...